The partnership between Clinical Trials Unit (CTU) in the University of Kelaniya, and RemediumOne was established with the primary objective of creating a centre of excellence for epidemiological and clinical research in Sri Lanka.
Our approach has been to conduct large-scale population, clinical and health systems research with a focus on innovative, cost-effective, scalable healthcare solutions in major NCDs neglected tropical diseases. The research we conduct aims to tackle some of the biggest public health challenges in the world and has the potential to improve the health of millions of people. Starting our journey with a pivotal trial in snakebite, we have worked in numerous therapeutic areas ranging from oncology to gastroenterology, and from cardiovascular disease, diabetes, and stroke to infectious diseases and rare diseases during the past years. Our aim was, and remains, to improve the lives of people by providing the highest standard of research evidence that can improve clinical practice and inform policy.